Medistep Healthcare Limited (NSE:MEDISTEP)
India · Delayed Price · Currency is INR 22.00
0.00 (0.00%)
At close: Oct 26, 2026
Medistep Healthcare Revenue
In the fiscal year ending March 31, 2026, Medistep Healthcare had annual revenue of 708.31M INR with 42.65% growth. Medistep Healthcare had revenue of 112.51M in the quarter ending June 30, 2024. That makes Medistep Healthcare the 38,558th largest company in the world by revenue and 3,499th in India.
Revenue
708.31M
Revenue Growth
+42.65%
P/S Ratio
0.44
Revenue / Employee
118.05M
Employees
6
Market Cap
312.61M
Revenue by Segment
- Trading 552.90M 78.1%
- Manufacturing 155.41M 21.9%
Fiscal year ended Mar 31, 2026 See the full Medistep Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 708.31M | 211.76M | 42.65% |
| Mar 31, 2025 | 496.55M | 105.83M | 27.09% |
| Mar 31, 2024 | 390.72M | 114.25M | 41.33% |
| Mar 31, 2023 | 276.47M | 200.22M | 262.61% |
| Mar 31, 2022 | 76.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.29B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.00B |
| Medico Intercontinental | 838.36M |
| Zenlabs Ethica | 496.22M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |